Mark For: CVCM™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88444536 |
Mark Literal Elements | CVCM |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-03-11 |
Basis | 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | No |
44D Filed | Yes |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | Jennifer Fraser |
Attorney Name | Jennifer Fraser |
Attorney Docket Number | 067249-0053 |
Law Office Assigned | L50 |
Employee Name | TENG, SIMON |
2019-05-23 | Application Filed |
2019-08-13 | Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED |
2019-08-13 | Status: Live/Pending |
2019-08-13 | Transaction Date |
2019-10-29 | Trademark Registered |
2020-03-11 | Location: PUBLICATION AND ISSUE SECTION |
2020-04-14 | Published |
2020-04-14 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
Party: | CureVac AG |
Address | Paul-Ehrlich-Str. 15 Tübingen GERMANY 72076 |
Legal Entity Type | Aktiengesellschaft (ag) |
Legal Entity State | GERMANY |
Drawing | JPEG | 2019-05-23 |
TEAS RF New Application | MULTI | 2019-05-23 |
Notation to File | XML | 2019-08-13 |
Offc Action Outgoing | XML | 2019-08-13 |
XSearch Search Summary | XML | 2019-08-13 |
Response to Office Action | APPLICATION/XML | 2020-02-03 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-02-11 |
Suspension Letter | XML | 2020-02-22 |
TEAS Response to Suspension Inquiry | MULTI | 2020-03-02 |
Amendment and Mail Process Complete | MULTI | 2020-03-06 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-03-07 |
Notice of Publication | XML | 2020-03-25 |
Notification Of Notice of Publication | XML | 2020-03-25 |
OG Publication Confirmation | APPLICATION/XML | 2020-04-14 |
IC 001. US 001 005 006 010 026 046. G & S: Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
IC 005. US 006 018 044 046 051 052. G & S: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements
IC 042. US 100 101. G & S: Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules
IC 044. US 100 101. G & S: Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes |
GS0011 | Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2020-04-14 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-04-14 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-03-25 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-03-06 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-05 | 70629 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-05 | 70629 |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-03-02 | |
SUSPENSION LETTER WRITTEN | 2020-02-22 | 83698 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2020-02-22 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2020-02-22 | 6332 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-10 | 70629 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-10 | 70629 |
ASSIGNED TO LIE | 2020-02-10 | 70629 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-02-03 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-08-13 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-08-13 | 83698 |
NON-FINAL ACTION E-MAILED | 2019-08-13 | 6325 |
ASSIGNED TO EXAMINER | 2019-08-10 | 83698 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-06-08 | |
NEW APPLICATION ENTERED IN TRAM | 2019-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.